Strontium ranelate is mainly used for the treatment and prevention of osteoporosis in postmenopausal women. Strontium ranelate has the dual pharmacological effect of inhibiting bone resorption and promoting bone formation. On the one hand, in osteoblast-enriched cells, it can increase the synthesis of collagen and non-collagen, and promote osteoblast-mediated bone formation by enhancing the proliferation of pre-osteoblasts. On the other hand, by reducing osteoclast differentiation and resorption activity, bone resorption is reduced, so that bone renewal is rebalanced and conducive to bone formation.
|Appearance||White crystalline powder||Conform|
|Loss on drying||17%-23%||21%|
|Appearance:||White crystalline powder|
High quality & competitive price
Fortunachem Provides Not Only Professional Chemical Products But Also Professional Help
Keeping you up-to-date with all the latest information, news, and events about Fortunachem!